NVAX
Novavax, Inc. NASDAQ Listed Dec 5, 1995$9.24
Mkt Cap $1.5B
52w Low $5.80
55.8% of range
52w High $11.97
50d MA $9.04
200d MA $8.22
P/E (TTM)
3.0x
EV/EBITDA
2.2x
P/B
—
Debt/Equity
-1.9x
ROE
-344.6%
P/FCF
-4.4x
RSI (14)
—
ATR (14)
—
Beta
2.65
50d MA
$9.04
200d MA
$8.22
Avg Volume
4.1M
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
21 Firstfield Road · Gaithersburg, MD 20878 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | BMO | -0.66 | 0.11 | +116.7% | 11.19 | -0.4% | -9.4% | -9.7% | -15.2% | -11.6% | -10.7% | — |
| Nov 6, 2025 | BMO | -1.08 | -0.62 | +42.6% | 7.59 | -1.6% | -2.0% | -6.3% | -2.0% | -5.1% | -7.0% | — |
| Aug 6, 2025 | BMO | -0.07 | 0.62 | +985.7% | 7.58 | +0.4% | +15.8% | +10.4% | +5.9% | +11.9% | +16.8% | — |
| May 8, 2025 | BMO | 0.71 | 2.93 | +312.7% | 6.66 | -0.8% | -10.2% | -4.8% | -7.1% | -10.5% | -5.6% | — |
| Feb 27, 2025 | BMO | -0.75 | -0.51 | +32.0% | 7.06 | +1.6% | +18.0% | +11.5% | +8.8% | +11.8% | +11.5% | — |
| Nov 12, 2024 | BMO | -0.87 | -0.76 | +12.6% | 8.46 | -0.2% | -8.2% | -14.7% | -13.5% | -7.4% | -5.4% | — |
| Aug 8, 2024 | BMO | 1.64 | 0.99 | -39.6% | 11.68 | -0.9% | -0.7% | +1.5% | +4.1% | +4.4% | +8.2% | — |
| May 10, 2024 | BMO | -1.04 | -1.05 | -1.0% | 8.88 | +9.1% | +47.6% | +51.8% | +45.3% | +62.2% | +46.5% | — |
| Feb 28, 2024 | BMO | -0.49 | -1.44 | -193.9% | 4.41 | -0.2% | +12.0% | +22.2% | +24.5% | +26.3% | +27.2% | — |
| Nov 9, 2023 | BMO | -1.82 | -1.26 | +30.8% | 6.71 | -0.4% | -7.0% | -6.6% | -7.0% | -7.6% | -13.1% | — |
| Aug 8, 2023 | BMO | -1.39 | 0.58 | +141.7% | 7.23 | +2.9% | -1.5% | +6.4% | +1.8% | +0.1% | +0.1% | — |
| May 9, 2023 | BMO | -3.38 | -3.41 | -0.9% | 9.52 | +5.1% | -5.6% | -6.6% | -11.2% | -14.8% | -19.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $11.19 | $11.15 | -0.4% | -9.4% | -9.7% | -15.2% | -11.6% | -10.7% |
| Jan 20 | BTIG | Maintains | Buy → Buy | — | $8.01 | $8.22 | +2.6% | +2.4% | +23.6% | +21.7% | +14.5% | +20.2% |
| Nov 18 | JP Morgan | Maintains | Underweight → Underweight | — | $6.80 | $6.61 | -2.8% | -3.4% | -6.8% | -8.5% | -4.9% | -2.5% |
| Nov 10 | B. Riley Securities | Maintains | Buy → Buy | — | $7.44 | $7.56 | +1.6% | -4.4% | +0.0% | -3.2% | -5.1% | -6.3% |
| Nov 4 | TD Cowen | Maintains | Hold → Hold | — | $7.91 | $7.69 | -2.8% | -5.1% | -2.8% | -4.0% | -5.9% | -10.1% |
| Oct 23 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.46 | $8.48 | +0.2% | -1.2% | +0.7% | +2.8% | +0.7% | -0.9% |
| Aug 20 | BofA Securities | Downgrade | Neutral → Underperform | — | $9.52 | $8.72 | -8.4% | -8.2% | -19.9% | -17.6% | -21.0% | -21.2% |
| Jul 22 | BofA Securities | Maintains | Neutral → Neutral | — | $7.17 | $7.19 | +0.3% | +0.7% | +9.3% | +6.6% | +4.2% | +1.5% |
| May 9 | JP Morgan | Maintains | Underweight → Underweight | — | $6.66 | $6.61 | -0.8% | -10.2% | -4.8% | -7.1% | -10.5% | -5.6% |
| Dec 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $9.07 | $9.10 | +0.3% | -3.3% | -2.8% | -0.6% | +0.4% | +1.8% |
| Nov 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.46 | $8.44 | -0.2% | -8.2% | -14.7% | -13.5% | -7.4% | -5.4% |
| Nov 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $9.01 | $8.05 | -10.7% | -6.1% | -13.8% | -19.9% | -18.8% | -13.1% |
| Aug 12 | B. Riley Securities | Maintains | Buy → Buy | — | $11.60 | $11.38 | -1.9% | +2.2% | +4.8% | +5.1% | +9.0% | +11.7% |
| Aug 12 | JP Morgan | Maintains | Underweight → Underweight | — | $11.60 | $11.38 | -1.9% | +2.2% | +4.8% | +5.1% | +9.0% | +11.7% |
| Aug 2 | B. Riley Securities | Maintains | Buy → Buy | — | $12.57 | $11.93 | -5.1% | -6.3% | -9.5% | -8.3% | -14.8% | -7.1% |
| Jul 30 | JP Morgan | Downgrade | Neutral → Underweight | — | $16.42 | $14.44 | -12.1% | -25.7% | -22.0% | -23.4% | -28.3% | -30.7% |
| Jun 14 | BofA Securities | Maintains | Neutral → Neutral | — | $15.05 | $14.32 | -4.9% | -4.3% | -6.6% | -8.4% | -6.6% | -7.0% |
| May 23 | B. Riley Securities | Maintains | Buy → Buy | — | $15.70 | $16.16 | +2.9% | -3.5% | -1.3% | -1.1% | -3.8% | -2.9% |
| May 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.88 | $9.69 | +9.1% | +47.6% | +51.8% | +45.3% | +62.2% | +46.5% |
| May 13 | TD Cowen | Maintains | Hold → Hold | — | $8.88 | $9.69 | +9.1% | +47.6% | +51.8% | +45.3% | +62.2% | +46.5% |
| May 10 | BofA Securities | Upgrade | Underperform → Neutral | — | $4.47 | $10.02 | +124.2% | +98.7% | +193.3% | +201.6% | +188.6% | +222.1% |
| Mar 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.94 | $5.09 | +3.0% | +9.1% | +11.1% | +12.8% | +13.6% | +13.6% |
| Feb 23 | B. Riley Securities | Maintains | Buy → Buy | — | $4.88 | $5.06 | +3.7% | +8.4% | +12.7% | +23.4% | -9.6% | +1.2% |
| Aug 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.12 | $7.16 | +0.6% | +8.0% | +3.4% | +1.7% | +1.7% | +0.1% |
| Aug 9 | B. Riley Securities | Upgrade | Neutral → Buy | — | $7.23 | $7.44 | +2.9% | -1.5% | +6.4% | +1.8% | +0.1% | +0.1% |
| May 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $9.52 | $10.01 | +5.1% | -5.6% | -6.6% | -11.2% | -14.8% | -19.7% |
| Mar 1 | B. Riley Securities | Downgrade | Buy → Neutral | — | $9.26 | $6.83 | -26.2% | -25.9% | -25.2% | -17.0% | -21.3% | -24.7% |
| Feb 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $9.88 | $10.02 | +1.4% | -1.0% | +0.5% | +3.1% | +1.1% | +1.4% |
| Jan 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Oct 14 | B. Riley Securities | Maintains | Buy → Buy | — | $21.28 | $21.50 | +1.0% | -7.6% | -4.5% | -12.5% | -15.7% | -19.3% |
| Sep 22 | JP Morgan | Downgrade | Neutral → Underweight | — | $25.87 | $24.63 | -4.8% | -13.3% | -18.8% | -27.1% | -22.5% | -24.2% |
| Aug 9 | Cowen & Co. | Maintains | Outperform → Outperform | — | $57.25 | $39.98 | -30.2% | -29.6% | -27.8% | -29.5% | -27.6% | -26.1% |
| Jun 8 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $47.54 | $52.31 | +10.0% | +5.4% | -12.7% | -14.6% | -23.7% | -18.6% |
| May 20 | BofA Securities | Maintains | Underperform → Underperform | — | $58.43 | $55.71 | -4.7% | -8.6% | -12.0% | -20.3% | -21.1% | -19.4% |
| Apr 26 | B. Riley Securities | Maintains | Buy → Buy | — | $50.21 | $50.00 | -0.4% | -5.6% | -7.5% | -11.8% | -10.2% | +7.1% |
| Mar 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $86.39 | $85.48 | -1.1% | -6.8% | -17.0% | -19.3% | -15.7% | -8.5% |
| Jan 21 | Cowen & Co. | Maintains | Outperform → Outperform | — | $90.36 | $87.36 | -3.3% | -6.3% | -12.1% | -14.6% | -12.4% | -19.3% |
| Dec 21 | JP Morgan | Maintains | Neutral → Neutral | — | $201.95 | $193.01 | -4.4% | -5.4% | -9.2% | -12.2% | -21.9% | -22.8% |
| Jun 15 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $207.71 | $200.00 | -3.7% | -9.9% | -15.2% | -13.4% | -16.0% | -12.9% |
| May 12 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $138.18 | $132.50 | -4.1% | -7.5% | -12.4% | -4.7% | +1.4% | +4.6% |
| May 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $138.18 | $132.50 | -4.1% | -7.5% | -12.4% | -4.7% | +1.4% | +4.6% |
| May 12 | JP Morgan | Downgrade | Overweight → Neutral | — | $138.18 | $132.50 | -4.1% | -7.5% | -12.4% | -4.7% | +1.4% | +4.6% |
| Mar 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $187.63 | $213.51 | +13.8% | +8.1% | +15.9% | +18.4% | +20.2% | +15.8% |
| Feb 18 | B. Riley Securities | Maintains | Buy → Buy | — | $273.98 | $271.99 | -0.7% | -3.2% | +1.4% | -10.5% | -11.2% | -12.4% |
| Feb 18 | B. Riley FBR | Maintains | Buy → Buy | — | $273.98 | $271.99 | -0.7% | -3.2% | +1.4% | -10.5% | -11.2% | -12.4% |
| Feb 17 | B. Riley FBR | Maintains | Buy → Buy | — | $262.70 | $249.20 | -5.1% | +4.3% | +1.0% | +5.8% | -6.7% | -7.4% |
| Feb 5 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $280.92 | $283.62 | +1.0% | +3.3% | +13.9% | +12.4% | +6.2% | +6.2% |
| Feb 1 | B. Riley FBR | Maintains | Buy → Buy | — | $220.94 | $242.52 | +9.8% | +21.4% | +19.7% | +28.6% | +27.1% | +31.3% |
| Feb 1 | B. Riley Securities | Maintains | Buy → Buy | — | $220.94 | $242.52 | +9.8% | +21.4% | +19.7% | +28.6% | +27.1% | +31.3% |
| Jan 31 | B. Riley FBR | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
No insider trades available.
Data updated apr 26, 2026 4:13pm
· Source: massive.com